Valuation : Tong Ren Tang Technologies Co. Ltd.

Market Cap 324.64Cr 378.47Cr 48Cr 42Cr 39Cr 36Cr 67Cr 4.59TCr 67Cr 462.53Cr 179.96Cr 2.33TCr 181.28Cr 177.34Cr 7.71TCr P/E 2026 *
7.14x
P/E 2027 * 6.34x
Enterprise Value 324.64Cr 378.47Cr 48Cr 42Cr 39Cr 36Cr 67Cr 4.59TCr 67Cr 462.53Cr 179.96Cr 2.33TCr 181.28Cr 177.34Cr 7.71TCr EV / Sales 2026 *
0.46x
EV / Sales 2027 * 0.43x
Free-Float
45.7%
Yield 2026 *
6.31%
Yield 2027 * 7.1%
28/08 Tong Ren Tang Technologies Co. Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 CI
28/08 Tong Ren Tang Technologies Co. Ltd. Enters New E-Commerce Service Cooperation Framework Agreement with Beijing Tong Ren Tang Shuzi Technology Co., Ltd CI
09/07 Tong Ren Tang Technologies Co. Ltd. Announces Executive Changes, Effective July 9, 2026 CI
29/06 Tong Ren Tang Chinese Medicine Enters Product Sales Contract with Tong Ren Tang Technologies MT
29/06 Beijing Tong Ren Tang Chinese Medicine Company Limited and Tong Ren Tang Technologies Co. Ltd. Enter Product Sales Framework Agreement CI
12/06 Tong Ren Tang Technologies Co. Ltd. Approves Final Dividend for the Year Ended 31 December 2025, Payable on 11 August 2026 CI
26/05 Tong Ren Tang Technologies receives certificate of registration for antelope horn powder capsules in Hong Kong RE
27/04 Tong Ren Tang Technologies Logs 169 Million Yuan in Q1 Profit MT
30/03 Tong Ren Tang's Profit Slides 24% in 2025; Shares Slip 3% MT
27/03 Tong Ren Tang Technologies Co. Ltd. Proposes Final Dividend for the Year Ended December 31, 2025, Payable on August 11, 2026 CI
27/03 Tong Ren Tang Technologies Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
27/03 Tong Ren Tang Technologies Co. Ltd. announces Annual dividend, payable on August 11, 2026 CI
06/02 Tong Ren Tang Technologies Co. Ltd. Announces Appointment of Mr. Siu, Paul Yu Hay as Independent Non-Executive Director and Changes in Board Committee Composition, Effective February 6, 2026 CI
1 day+3.38%
1 week-4.53%
Current month-13.21%
1 month-13.21%
3 months-13.70%
6 months-27.78%
Current year-30.73%
1 week 2.96
Extreme 2.955
3.3
1 month 2.96
Extreme 2.955
3.57
Current year 2.96
Extreme 2.955
4.56
1 year 2.96
Extreme 2.955
5.02
3 years 2.96
Extreme 2.955
7.03
5 years 2.96
Extreme 2.955
9.28
10 years 2.96
Extreme 2.955
16
Manager TitleAgeSince
Chief Executive Officer 58 04/06/2025
Comptroller/Controller/Auditor 48 04/06/2025
Corporate Secretary 37 09/07/2026
Director TitleAgeSince
Director/Board Member 67 10/02/2011
Director/Board Member 69 12/06/2018
Director/Board Member 82 12/06/2018
Change 5-day change 1-year change 3-year change Capi.($)
+2.20%-4.53%-37.27%-51.43% 54Cr
+0.78%+2.15%-12.49%-6.96% 1.33TCr
-2.41%+0.50%-33.04%-56.86% 499.01Cr
-3.11%-1.57%-8.27%-7.32% 465.93Cr
-1.55%-3.16%-2.75%-31.25% 401.78Cr
-1.07%+1.95%-21.84%+3.65% 359.48Cr
+3.31%+6.11%+0.23%-0.92% 343.15Cr
-1.41%-1.94%-11.14%+5.99% 330.63Cr
-1.65%-3.87%-23.53%-14.45% 237.78Cr
-1.52%+1.41%-27.89%-15.73% 172.3Cr
Average -0.52%-0.35%-17.80%-17.53% 418.98Cr
Weighted average by Cap. -0.58%-0.19%-14.76%-14.20%

Financials

2026 *2027 *
Net sales 698.2Cr 813.96Cr 103.84Cr 89Cr 84Cr 77Cr 143.96Cr 9.88TCr 144.99Cr 994.75Cr 387.03Cr 5.01TCr 389.88Cr 381.4Cr 17TCr 756.3Cr 881.7Cr 112.48Cr 97Cr 91Cr 83Cr 155.94Cr 11TCr 157.05Cr 1.08TCr 419.24Cr 5.43TCr 422.32Cr 413.14Cr 18TCr
Net income 45Cr 53Cr 6.76Cr 5.82Cr 5.46Cr 4.99Cr 9.37Cr 643.15Cr 9.44Cr 65Cr 25Cr 326.13Cr 25Cr 25Cr 1.08TCr 51Cr 60Cr 7.64Cr 6.58Cr 6.17Cr 5.64Cr 11Cr 726.64Cr 11Cr 73Cr 28Cr 368.47Cr 29Cr 28Cr 1.22TCr
Net Debt - -
Logo Tong Ren Tang Technologies Co. Ltd.
Tong Ren Tang Technologies Co Ltd is a China-based company principally engaged in the production and distribution of Chinese medicine. The Company primarily operates its businesses through two segments. The Company segment is mainly engaged in the manufacture and sale of Chinese medicine. Tong Ren Tang Chinese Medicine segment is mainly involved in manufacturing, retail and wholesale of Chinese medicine products and healthcare products, and provision of Chinese medical consultation and treatments services. The Company is also engaged in processing and purchasing of Chinese medicinal raw materials, sales of medicinal products, medical services and advertising business. The Company mainly conducts its businesses in the domestic market.
Employees
3,951
Date Price Change Volume
01/26/01 HK$3.020 +2.20% 16,59,000
31/26/31 HK$2.955 -10.18% 1,88,89,925
28/26/28 HK$3.290 +2.33% 5,42,146
27/26/27 HK$3.215 -1.68% 8,30,000
26/26/26 HK$3.270 +2.67% 11,49,000
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.535CNY
Average target price
4.601CNY
Spread / Average Target
+81.52%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 1666 Stock